C-Suite

The landscape for GLP-1 medications is shifting significantly in 2026, especially in southern states like Mississippi, Alabama, and Florida.

The recent settlement involving Cigna over inaccurate provider directories, often called "ghost networks," has brought new attention to the challenges faced by health plans and employers under ERISA (Employee Retirement Income Security Act).